Patent · US Active

Humanized anti-complement factor C1Q antibodies

US10316081B2 · kind B2 · utility

5Cited by
3References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 5, 2015
Grant dateJun 11, 2019
Priority date—
Expiry dateFeb 4, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/4716
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure is directed to humanized anti-C1q antibodies and methods of using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.